Sort
30,917 grants matching “tumor microenvironment”
Core C - Cell Culture and iPS Core (CCiC)
$270,879Hiroshi Nakagawa · Columbia University Health Sciences · P01 · FY2023 · CA
Project 3
$270,874Deirdre R. Meldrum · Arizona State University-Tempe Campus · U54 · FY2013 · CA
Targeting JAK2 Kinase in Lymphoma
$270,847Mamta Gupta · University Of Iowa · P50 · FY2015 · CA
Role of Integrins and bone matrix in prostate cancer
$270,840Tatiana V Byzova · Cleveland Clinic Lerner Com-Cwru · R01 · FY2007 · CA
Overcoming resistance to cancer immunotherapy by targeting MDSC-derived adenosine
$270,817Kavitha Yaddanapudi · University Of Louisville · P20 · FY2022 · GM
Exploiting Therapeutic Vulnerabilities
$270,796William A Weiss · Children'S Hospital Of Los Angeles · P01 · FY2018 · CA
Bench to Beside and Back translational immuno-onocology-Cures
$270,790James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Estrogen Biotransformations and Breast Cancer Etiology
$270,783Robert W Brueggemeier · Ohio State University · R01 · FY2006 · CA
Therapeutic anti-angiogenesis and tumor microenvironment
$270,774Timothy F Lane · University Of California Los Angeles · R01 · FY2006 · CA
Tumor models for the study of inflammation and oncogenesis
$270,744Robert Wiltrout · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Localization and Function of iNKT Cells in Neuroblastoma
$270,713Children'S Hospital Los Angeles · R01 · FY2005 · CA
HGF AND THE PATHOLOGY OF LUNG CANCER
$270,656University Of Pittsburgh At Pittsburgh · R01 · FY2002 · CA
Defining tumor-infiltrating B cell signatures associated with T cell mediated antitumor immunity in human lung adenocarcinoma
$270,631Corey Taylor Watson · University Of Louisville · P20 · FY2020 · GM
HGF AND THE PATHOLOGY OF LUNG CANCER
$270,599University Of Pittsburgh At Pittsburgh · R01 · FY2001 · CA
Biomarkers of the Proinflammatory Response and Elements of Immune Suppression
$270,551Ahmad A. Tarhini · University Of Pittsburgh At Pittsburgh · P50 · FY2016 · CA
Project 1: Targeting Metabolic Vulnerabilities in Lung Cancer
$270,549Ralph J Deberardinis · Ut Southwestern Medical Center · P50 · FY2022 · CA
Project 1: Targeting Metabolic Vulnerabilities in Lung Cancer
$270,548Ralph J Deberardinis · Ut Southwestern Medical Center · P50 · FY2023 · CA
Core 2: Human Specimen and Organic Core (HSO Core)
$270,543Herve Tiriac · Salk Institute For Biological Studies · P01 · FY2025 · CA
Cell-Cell &Cell Stroma Regulation in Oral Premalignancy
$270,530New York University · R01 · FY2005 · DE
New Model of the Tumor Microenvironment
$270,485University Of Calif-Los Alamos Nat Lab · R21 · FY2004 · CA
Reimagining Pharmaceutical Drug Development in Oncology with a Biomimetic Platform
$270,428Charles Keller · Teo Therapeutics Incorporated · R43 · FY2024 · OD
LIGHT for the Recognition and Eradication of Advanced Cancer
$270,419Yang-Xin Fu · University Of Chicago · P01 · FY2009 · CA
IMMUNOTHERAPY WITH CAR T CELLS
$270,400Carl H. June · University Of Pennsylvania · R01 · FY2016 · CA
IMMUNOTHERAPY WITH CAR T CELLS
$270,400Carl H. June · University Of Pennsylvania · R01 · FY2015 · CA
The therapeutic potential of maspin in prostate cancer
$270,380Shijie Sheng · Wayne State University · R01 · FY2011 · CA